Sevoflurane Articles
India's Piramal buys Minrade in $40M deal
15 January 2009
Adeka debuts new anesthetic, other Minrad prods
23 June 2008
Minrad completes sevoflurane API line validation
17 December 2007
Japanese generic drug listings for November
21 November 2007
MINRAD's sevoflurane approved in Japan
26 March 2007
Baxter launches sevoflurane in China
19 December 2005
Baxter/Abbott patent dispute reinstated
14 July 2003
Abbott Labs UK receives special award for innovation
24 February 2003
Abbott sales growth driven by pharma
13 July 2001
US pharma business driving Abbott
17 April 2001
US pharma business driving Abbott
12 April 2001
"Solid Performance" From Abbott In 1st Qtr
21 April 1997
Abbott Labs' 3rd Qtr Net Earnings Up 8.7%
16 October 1995
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Strong International Sales For US Cos In 2nd Qtr
31 July 1995
Abbott's Ultane Approved In USA
19 June 1995
Abbott Files NDA For Sevorane Anesthetic
28 November 1994
PROFITS AND SALES RISE AT MARUISHI
18 April 1994
ABBOTT'S HYTRIN GETS BPH APPROVAL IN USA
11 October 1993
MARUISHI'S SEVOFRANE LAUNCHED IN CHINA
9 August 1993
MARUISHI LICENSES ANESTHETIC
9 November 1992
Showing 1-24 of 24 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
